Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 132,929,348
- Total 13F shares
- 55,307,620
- Share change
- +689,120
- Total reported value
- $315,754,570
- Put/Call ratio
- 128%
- Price per share
- $5.71
- Number of holders
- 168
- Value change
- +$4,958,367
- Number of buys
- 78
- Number of sells
- 74
Quarterly Holders Quick Answers
What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05156V102:
Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
9.2%
|
12,260,000
|
$61,422,600 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.5%
|
8,662,978
|
$43,401,521 | — | 31 Mar 2024 | |
| NEA Management Company, LLC |
13F
|
Company |
3%
|
3,969,834
|
$19,888,868 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
2,770,864
|
$13,882,029 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.6%
|
2,152,154
|
$10,782,292 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.5%
|
2,059,107
|
$10,316,126 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.5%
|
2,050,000
|
$10,270,500 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,603,080
|
$8,031,430 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
1,531,617
|
$7,673,401 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.98%
|
1,304,138
|
$6,533,732 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.87%
|
1,150,347
|
$5,763,238 | — | 31 Mar 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.78%
|
1,040,530
|
$5,213,055 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
1,022,792
|
$5,124,187 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.57%
|
759,269
|
$3,803,938 | — | 31 Mar 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.46%
|
615,000
|
$3,081,150 | — | 31 Mar 2024 | |
| Michael Robert Martin |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
259,162
|
$2,918,164 | — | 02 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.41%
|
538,958
|
$2,700,180 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.38%
|
500,555
|
$2,507,781 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.33%
|
436,882
|
$2,188,779 | — | 31 Mar 2024 | |
| LEVEL FOUR ADVISORY SERVICES, LLC |
13F
|
Company |
0.18%
|
236,800
|
$2,128,832 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
411,211
|
$2,060,168 | — | 31 Mar 2024 | |
| Volker Knappertz |
3/4/5
|
EVP, Research and Development |
—
class O/S missing
|
319,128
|
$1,946,681 | — | 27 Feb 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.28%
|
377,322
|
$1,890,383 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.26%
|
349,204
|
$1,750,000 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
337,757
|
$1,692,162 | — | 31 Mar 2024 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.23%
|
308,500
|
$1,551,755 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.23%
|
307,931
|
$1,542,735 | — | 31 Mar 2024 | |
| Marex Group plc |
13F
|
Company |
0.23%
|
300,000
|
$1,503,000 | — | 31 Mar 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.22%
|
294,201
|
$1,473,947 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.22%
|
290,400
|
$1,454,904 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.22%
|
288,875
|
$1,447,264 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.2%
|
268,500
|
$1,345,185 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.2%
|
268,403
|
$1,344,699 | — | 31 Mar 2024 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.19%
|
247,052
|
$1,237,731 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.18%
|
244,600
|
$1,225,000 | — | 31 Mar 2024 | |
| Campbell & CO Investment Adviser LLC |
13F
|
Company |
0.18%
|
237,095
|
$1,187,846 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.17%
|
219,468
|
$1,099,535 | — | 31 Mar 2024 | |
| Neil Solomons |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
288,453
mixed-class rows
|
$1,024,131 | — | 02 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.15%
|
200,782
|
$1,005,918 | — | 31 Mar 2024 | |
| Advisory Services Network, LLC |
13F
|
Company |
0.14%
|
186,090
|
$932,311 | — | 31 Mar 2024 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0.14%
|
185,275
|
$928,228 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.14%
|
183,892
|
$921,285 | — | 31 Mar 2024 | |
| George M. Milne Jr. |
3/4/5
|
Director |
—
class O/S missing
|
78,733
|
$886,534 | — | 18 May 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
172,724
|
$865,348 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.13%
|
172,153
|
$862,487 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.12%
|
160,148
|
$802,342 | — | 31 Mar 2024 | |
| Robert Bindert Huizinga |
3/4/5
|
EVP of Research |
—
mixed-class rows
|
238,665
mixed-class rows
|
$781,208 | — | 02 Mar 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.11%
|
141,055
|
$706,685 | — | 31 Mar 2024 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.1%
|
136,288
|
$682,803 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
135,500
|
$678,855 | — | 31 Mar 2024 |
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2024
As of 30 Jun 2024,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
168 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,307,620 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., NEA Management Company, LLC, STATE STREET CORP, TANG CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, Nuveen Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and Rock Springs Capital Management LP.
This page lists
170
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
173
Q2 2024 holders
168
Holder diff
-5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.